复方血栓通胶囊、石斛夜光丸联合氨碘肽滴眼液治疗玻璃体混浊的效果观察  

The clinical effect of compound Xueshuantong capsule Dendrobium luminous pill combined with amiotide eye drops in the treatment of vitreous opacity

作　　者：何陈亮[1] 胡振仙[1] 李永波[1] 

机构地区：[1]浙江省立同德医院眼科,浙江省杭州310012

出　　处：《中国基层医药》2015年第12期1791-1793,共3页Chinese Journal of Primary Medicine and Pharmacy

基　　金：浙江省中医药科研计划项目（2010ZA012）

摘　　要：目的：观察复方血栓通胶囊、石斛夜光丸联合氨碘肽滴眼液治疗玻璃体混浊的临床疗效。方法采用随机数字表法将120例玻璃体混浊患者分为两组，每组60例。对照组采用常规氨碘肽滴眼液进行治疗，观察组在常规治疗的基础上，联合应用复方血栓通胶囊、石斛夜光丸进行治疗，观察并比较两组患者经过治疗后的临床效果。结果观察组总有效率为66．67％，明显高于对照组的38．33％（χ^2＝9．09，P ＜0．05）；观察组患者中青年玻璃体混浊患者总有效率（78．79％）明显高于老年玻璃体混浊患者（51．85％），差异有统计学意义（χ^2＝8．24，P ＜0．05）；观察组治疗后两年内玻璃体混浊复发率为28．33％，明显低于对照组的58．33％（χ^2＝11．67，P ＜0．05）。结论复方血栓通胶囊、石斛夜光丸联合氨碘肽滴眼液对玻璃体混浊患者的治疗具有积极作用，可提高临床总有效率，恢复患者视力，避免玻璃体混浊的再次复发，安全、有效，应该在临床上广泛应用。Objective To explore the effect of compound Xueshuantong capsule Dendrobium luminous pill combined with amiotide eye drops in the treatment of vitreous opacity.Methods According to the digital table, 120 patients with vitreous opacity were divided into two groups,60 cases in each group.The control group was given conventional amiotide eye drops treatment,and the observation group was given compound Xueshuantong capsule Den-drobium luminous pill for treatment on the basis of conventional therapy.The clinical effect was observed and com-pared after treatment.Results The total effective rate in the observation group was 66.67%,which was significantly higher than 38.33% of the control group（χ^2 =9.09,P 〈0.05）.The total effective rate of young patients in the obser-vation group was 78.79%,which was significantly higher than 51.85% of the elderly patients（χ^2 =8.24,P 〈0.05）. The vitreous opacities total effective rate of the observation group after treatment within two years was 58.33%,which was significantly higher than 28.33% of the control group（χ^2 =11.67,P 〈0.05）.Conclusion Compound Xue-shuantong capsule Dendrobium luminous pill combined with ammonia iodine peptide drop has a positive effect in the treatment of ocular fluid of vitreous opacity,improve the clinical total effective rate,recovery of affected vision,and avoid the recurrence of vitreous opacity after operation,has the advantages of safety,effectiveness,which should be widely applied in clinic.

关 键 词：眼疾病 玻璃体 氨碘肽滴眼液 医学 中国传统 

分 类 号：R779.1[医药卫生—眼科]